Sanders calls on USPTO to block Gilead patent extension
US presidential candidate Bernie Sanders has called on the US Patent and Trademark Office to block extensions to two Gilead Sciences patents covering HIV prevention drugs including Descovy.
TAG supports opposition of Sanofi TB drug patents in India
Treatment Action Group, a US-based organisation focused on research of diseases such as HIV/AIDS and tuberculosis, has applauded an opposition that aims to block Sanofi from patenting a new TB drug in India.
Medtronic sued over artificial heart valves
Medtronic, the world’s largest medical devices company, is facing a patent infringement lawsuit over its line of artificial heart valves.
Takeda sues Mylan over gout generic
Takeda has sued Mylan for patent infringement and breach of a licencing agreement over Takeda’s Colcrys drug.
Generic drugmaker to pay $3m antitrust fine
New Jersey-based generic drugmaker Rising Pharmaceuticals has admitted to conspiring to fix prices and allocate customers for a generic hypertension drug.
US Senate Committee votes in Stephen Hahn as FDA Commissioner
The US Senate Committee on Health, Education, Labor and Pensions has approved President Donald Trump’s nomination for Stephen Hahn to serve as the new commissioner of the Food and Drug Administration.
Astellas doubles down on gene therapy with $3bn Audentes deal
Astellas is set to buy US-based Audentes Therapeutics for approximately $3 billion, as the Japanese pharmaceutical company looks to boost its gene therapy expertise.
Barnes & Thornburg adds 17, creates three new offices
Barnes & Thornburg has recruited a new life sciences patent group from the IP boutique Brinks, Gilson & Lione.
US considers shortening marketing exclusivity to push forward USMCA
The Trump administration is considering shortening the period that big pharma companies’ biologic drugs are protected by marketing exclusivity from biosimilar competition.
Genus sues Mallinckrodt over secret cocaine hydrochloride studies
Genus Lifesciences is suing pharmaceutical company Mallinckrodt for misusing trade secrets related to a cocaine hydrochloride formulation.
